Cure Today10h
Understanding the Benefit of Subcutaneous Versus IV Opdivo in Patients With Solid Tumors
Dr. Eric K. Singhi discusses the benefit of subcutaneous immunotherapy following the FDA approval of subcutaneous Opdivo for ...
The American Journal of Managed Care11h
Subcutaneous Ocrelizumab Well Tolerated in Patients With MS
Subcutaneous ocrelizumab (SC OCR) was found to be safe for patients with relapsing and primary progressive multiple sclerosis ...
The ‘inner terror’ of lethal injection is cruel, law prof argues in bid to stop Gunches execution
Death by lethal injection looks like the condemned person just went to sleep. But looks can be deceiving. Anesthesiologists ...
The American Journal of Managed Care6d
FDA Approves First Subcutaneous Nivolumab Injection in Most Solid Tumors
FDA approves the first subcutaneous version of nivolumab, making PD-1 inhibitors available to new groups of patients.
FDA approves injectable version of Bristol Myers Squibb's cancer drug Opdivo (Dec. 27)
The U.S. Food and Drug Administration said on Friday that it has approved an injectable version of Bristol Myers Squibb's ...
FiercePharma6d
Bristol Myers celebrates 10 years of Opdivo with FDA approval for subcutaneous version
Almost exactly 10 years after the FDA’s initial FDA approval for Bristol Myers Squibb’s Opdivo as the first PD-1 inhibitor in ...
An Arizona prisoner is asking to be executed sooner than the state wants
PHOENIX (AP) — An Arizona death row prisoner asked the state’s highest court to skip legal formalities and schedule his ...
After holiday pause, South Carolina begins scheduling executions again
South Carolina's Supreme Court set a Jan. 31 date for the state's next execution after allowing a pause for the Christmas ...
Tennessee is refusing to release its new execution manual. Here is why it matters.
Just days after Tennessee announced it had a new manual for executing death row inmates, the state's top prison officials ...